RTsafe

RTsafe is a Greece-based startup founded in 2014 that specializes in medical technology, with a mission to enhance radiotherapy for cancer using 3D printing technology. Their slogan, "RTsafe enhances radiotherapy for cancer with 3D printing technology and anatomically accurate effigies. Increases precision and safety." encapsulates their core focus. The company's innovative methodology aims to improve quality assurance and increase the safety and precision of radiotherapy treatments for various medical conditions, particularly cancer. RTsafe's pioneering approach involves the use of advanced 3D printing technology to create lifelike anatomical models that accurately represent patients' anatomy. These models enable healthcare professionals to simulate treatments and implement more targeted, patient-specific interventions. Additionally, manufacturers of radiotherapy technology can utilize these models to optimize their products, ultimately leading to more efficient treatment and reduced risk for the patient. The company received a recent $1.00M Convertible Note investment on 01 March 2019, with VentureFriends and Simanta Das participating as investors. RTsafe's focus on leveraging cutting-edge technology to improve patient outcomes in the healthcare industry, particularly in the field of cancer treatment, positions it as a promising investment opportunity for venture capital firms seeking to support innovative solutions in the health care sector. For more information, visit their website at www.rt-safe.com.